Granules India has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, the 24th day of May 2018 at 10.00 AM at the registered office of the Company situated at 2nd Floor, 3rd Block, My Home Hub, Madhapur, Hyderabad (TS), to consider and approve the Audited Financial Results for the fourth quarter and financial year ended March 31, 2018 and the recommendation of final dividend for the FY 2017-18, if any. Further, informed that Insider Trading Window of Granules India is closed from 18lh May 2018 to 26‘h May 2018.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: